Diabetes in pregnancy

Glycemia control guidelines and rationale

Scarlett D. Karakash, Francine H. Einstein

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Purpose Of Review: Little consensus exists on the definition of gestational diabetes (GDM), how the condition should be diagnosed, and if interventions for mild maternal hyperglycemia are of any benefit to the mother or fetus. Today, after several large multicenter clinical trials, we are closer than ever to a national and international consensus. Recent Findings: Glucose tolerance in pregnancy is a continuum, which has a fundamental link to fetal growth. The relationship between maternal glycemia and adverse outcomes is continuous, with no distinct inflection point for increased risk. As a result, any cut-off for the diagnosis of GDM is somewhat arbitrary. Treatment for GDM, even mild cases, significantly reduces the rate of certain adverse perinatal and maternal outcomes, warranting intervention. Summary: Clinical guidelines for the diagnosis of GDM are expected to change in the near future provided that recommendations from the International Association of Diabetes and Pregnancy Study Group are accepted by professional organizations. The criteria for the diagnosis will likely be based on a single 75 g, 2-h oral glucose tolerance test with at least one abnormal value. The proposed threshold values are based on an international consensus regarding risk of adverse pregnancy outcomes. The public health implications for these changes are anticipated to be significant.

Original languageEnglish (US)
Pages (from-to)99-103
Number of pages5
JournalCurrent Opinion in Endocrinology, Diabetes and Obesity
Volume18
Issue number2
DOIs
StatePublished - Apr 2011

Fingerprint

Pregnancy in Diabetics
Mothers
Guidelines
Pregnancy
Gestational Diabetes
Pregnancy Outcome
Glucose Tolerance Test
Fetal Development
Hyperglycemia
Multicenter Studies
Fetus
Public Health
Clinical Trials
Glucose

Keywords

  • gestational diabetes
  • glucose intolerance
  • perinatal outcome
  • pregnancy

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Nutrition and Dietetics

Cite this

Diabetes in pregnancy : Glycemia control guidelines and rationale. / Karakash, Scarlett D.; Einstein, Francine H.

In: Current Opinion in Endocrinology, Diabetes and Obesity, Vol. 18, No. 2, 04.2011, p. 99-103.

Research output: Contribution to journalArticle

Karakash, Scarlett D. ; Einstein, Francine H. / Diabetes in pregnancy : Glycemia control guidelines and rationale. In: Current Opinion in Endocrinology, Diabetes and Obesity. 2011 ; Vol. 18, No. 2. pp. 99-103.
@article{befccce229874bebb07ca3af4d5e4b24,
title = "Diabetes in pregnancy: Glycemia control guidelines and rationale",
abstract = "Purpose Of Review: Little consensus exists on the definition of gestational diabetes (GDM), how the condition should be diagnosed, and if interventions for mild maternal hyperglycemia are of any benefit to the mother or fetus. Today, after several large multicenter clinical trials, we are closer than ever to a national and international consensus. Recent Findings: Glucose tolerance in pregnancy is a continuum, which has a fundamental link to fetal growth. The relationship between maternal glycemia and adverse outcomes is continuous, with no distinct inflection point for increased risk. As a result, any cut-off for the diagnosis of GDM is somewhat arbitrary. Treatment for GDM, even mild cases, significantly reduces the rate of certain adverse perinatal and maternal outcomes, warranting intervention. Summary: Clinical guidelines for the diagnosis of GDM are expected to change in the near future provided that recommendations from the International Association of Diabetes and Pregnancy Study Group are accepted by professional organizations. The criteria for the diagnosis will likely be based on a single 75 g, 2-h oral glucose tolerance test with at least one abnormal value. The proposed threshold values are based on an international consensus regarding risk of adverse pregnancy outcomes. The public health implications for these changes are anticipated to be significant.",
keywords = "gestational diabetes, glucose intolerance, perinatal outcome, pregnancy",
author = "Karakash, {Scarlett D.} and Einstein, {Francine H.}",
year = "2011",
month = "4",
doi = "10.1097/MED.0b013e3283446ed2",
language = "English (US)",
volume = "18",
pages = "99--103",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Diabetes in pregnancy

T2 - Glycemia control guidelines and rationale

AU - Karakash, Scarlett D.

AU - Einstein, Francine H.

PY - 2011/4

Y1 - 2011/4

N2 - Purpose Of Review: Little consensus exists on the definition of gestational diabetes (GDM), how the condition should be diagnosed, and if interventions for mild maternal hyperglycemia are of any benefit to the mother or fetus. Today, after several large multicenter clinical trials, we are closer than ever to a national and international consensus. Recent Findings: Glucose tolerance in pregnancy is a continuum, which has a fundamental link to fetal growth. The relationship between maternal glycemia and adverse outcomes is continuous, with no distinct inflection point for increased risk. As a result, any cut-off for the diagnosis of GDM is somewhat arbitrary. Treatment for GDM, even mild cases, significantly reduces the rate of certain adverse perinatal and maternal outcomes, warranting intervention. Summary: Clinical guidelines for the diagnosis of GDM are expected to change in the near future provided that recommendations from the International Association of Diabetes and Pregnancy Study Group are accepted by professional organizations. The criteria for the diagnosis will likely be based on a single 75 g, 2-h oral glucose tolerance test with at least one abnormal value. The proposed threshold values are based on an international consensus regarding risk of adverse pregnancy outcomes. The public health implications for these changes are anticipated to be significant.

AB - Purpose Of Review: Little consensus exists on the definition of gestational diabetes (GDM), how the condition should be diagnosed, and if interventions for mild maternal hyperglycemia are of any benefit to the mother or fetus. Today, after several large multicenter clinical trials, we are closer than ever to a national and international consensus. Recent Findings: Glucose tolerance in pregnancy is a continuum, which has a fundamental link to fetal growth. The relationship between maternal glycemia and adverse outcomes is continuous, with no distinct inflection point for increased risk. As a result, any cut-off for the diagnosis of GDM is somewhat arbitrary. Treatment for GDM, even mild cases, significantly reduces the rate of certain adverse perinatal and maternal outcomes, warranting intervention. Summary: Clinical guidelines for the diagnosis of GDM are expected to change in the near future provided that recommendations from the International Association of Diabetes and Pregnancy Study Group are accepted by professional organizations. The criteria for the diagnosis will likely be based on a single 75 g, 2-h oral glucose tolerance test with at least one abnormal value. The proposed threshold values are based on an international consensus regarding risk of adverse pregnancy outcomes. The public health implications for these changes are anticipated to be significant.

KW - gestational diabetes

KW - glucose intolerance

KW - perinatal outcome

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=79952445496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952445496&partnerID=8YFLogxK

U2 - 10.1097/MED.0b013e3283446ed2

DO - 10.1097/MED.0b013e3283446ed2

M3 - Article

VL - 18

SP - 99

EP - 103

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 2

ER -